AI assistant
Sending…
REGENXBIO Inc. — Director's Dealing 2018
Mar 2, 2018
32827_dirs_2018-03-02_94ef6062-edaf-4731-afd9-94e43758805e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REGENXBIO Inc. (RGNX)
CIK: 0001590877
Period of Report: 2018-02-28
Reporting Person: Vasista Vittal (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-02-28 | Common Stock | S | 5000.00 | $30.00 | Disposed | 102283.00 | Direct |
Footnotes
F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan.
More from REGENXBIO Inc.
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Proxy Solicitation & Information Statement
2026
Apr 14
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Feb 10
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Jan 29
Regulatory Filings
2026
Jan 28
Major Shareholding Notification
2026
Jan 21